Kirkland, Wash.-based Cardiac Insight is still seeking $5.5 million in a round of C-1 financing that recently generated $4.5 million to support sales, marketing and distribution of its Cardea Solo 7-day ECG sensor. The company also created a scientific advisory board, appointing former Heart Rhythm Society President Robert Hauser as chair, and also tapped OncoResponse CEO Clifford Stocks to serve on its board of directors.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information
that is changing your industry today, hand-curated by our professional editors from
thousands of sources and delivered straight to your inbox.